STOCK TITAN

Liberty Defense Announces Pricing of its U.S. Initial Public Offering

(Neutral)
(Neutral)
Tags

Liberty Defense (DETX) priced a U.S. initial public offering of 3,673,638 common shares at $4.50 and pre-funded warrants for 770,807 shares at $4.4999, raising gross proceeds of approximately $20 million. The shares are expected to begin trading on Nasdaq on April 22, 2026 and closing is expected April 23, 2026, subject to customary conditions and TSXV approval. The company granted underwriters a 30-day option for 666,666 additional shares. CEO William Frain intends to buy 5,555 shares for about $25,000. A Form F-1 was declared effective March 31, 2026.

Loading...
Loading translation...

Positive

  • Gross proceeds of approximately $20 million expected
  • Nasdaq listing scheduled to begin April 22, 2026 under symbol DETX
  • Underwriter overallotment option for 666,666 additional shares
  • CEO participation of 5,555 shares (~$25,000) indicating insider interest

Negative

  • Share issuance of 3,673,638 common shares will dilute existing holders
  • Four-month hold on securities issued to Canadian purchasers limits near-term liquidity
  • Closing contingent on TSXV approval and customary conditions, creating execution risk

Market Context

This announcement prices Liberty Defense’s U.S. IPO at $4.50 per share for 3,673,638 common shares p...
Analysis

This announcement prices Liberty Defense’s U.S. IPO at $4.50 per share for 3,673,638 common shares plus pre-funded warrants and sets an expected Nasdaq Capital Market listing under “DETX”. It follows earlier confidential and public F‑1 filings that produced volatile reactions. Investors may focus on gross proceeds of about $20 million, CEO participation of 5,555 shares, and how added capital balances dilution against the company’s ongoing commercialization plans.

Key Figures

Common shares offered: 3,673,638 shares IPO price: $4.50 per share Pre-funded warrants: 770,807 warrants at $4.4999 +5 more
8 metrics
Common shares offered 3,673,638 shares U.S. initial public offering size
IPO price $4.50 per share Public offering price for U.S. IPO
Pre-funded warrants 770,807 warrants at $4.4999 Pre-funded warrants in lieu of common shares
Gross proceeds $20 million Expected gross proceeds before fees and expenses
Over-allotment option 666,666 shares 30-day underwriter option to cover over-allotments
Nasdaq trading start April 22, 2026 Expected start of trading under symbol “DETX”
CEO participation 5,555 shares; ~$25,000 Shares CEO intends to purchase in the offering
F-1 effective date March 31, 2026 Form F-1 registration statement declared effective by SEC

Previous IPO,offering Reports

2 past events · Latest: Feb 06 (Positive)
Same Type Pattern 2 events
Date Event Sentiment 24h Move Catalyst
Feb 06 IPO filing update Positive +24.0% Public Form F-1 filing and Nasdaq application for proposed U.S. IPO.
Jan 20 Confidential IPO draft Positive -7.7% Confidential draft Form F-1 submission signaling intent for U.S. IPO.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Past U.S. IPO milestones produced volatile, mixed reactions: one strong gain and one sharp decline, suggesting uneven sentiment around equity-raising and listing steps.

Recent Company History

Over recent months, Liberty Defense has advanced a multi-step U.S. IPO process. It first confidentially submitted a draft Form F‑1 on Jan 20, 2026, then publicly filed a registration statement on Feb 6, 2026. Those announcements drove large but opposing price reactions of -7.67% and +24%, highlighting investor uncertainty around dilution and U.S. listing. Today’s pricing news continues that IPO,offering trajectory toward a Nasdaq Capital Market listing.

Key Terms

pre-funded warrants, over-allotments, nasdaq capital market, multilateral instrument 61-101, +4 more
8 terms
pre-funded warrants financial
"pre-funded warrants to purchase 770,807 common shares at a purchase price of $4.4999"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
over-allotments financial
"30-day option to purchase up to an additional 666,666 common shares solely to cover over-allotments"
An over-allotment is a temporary extra batch of shares that the underwriters of a stock offering are allowed to sell beyond the original amount, with the right to buy those shares back later. Think of it as spare tickets sold to meet demand and then reclaimed if needed to keep the market orderly; it helps stabilize the stock price after an offering and can affect short-term supply and potential dilution, which matters to investors tracking price and ownership stakes.
nasdaq capital market financial
"The common shares are expected to begin trading on the Nasdaq Capital Market on April 22, 2026"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
multilateral instrument 61-101 regulatory
"constitutes a “related party transaction” within the meaning of Multilateral Instrument 61-101"
Multilateral Instrument 61-101 is a securities regulation that sets rules for certain corporate deals—like mergers, asset sales, or related-party transactions—to protect minority shareholders by requiring extra disclosure, independent valuation and, in many cases, formal shareholder approval. Think of it as an impartial referee and checklist that forces companies to show the full playbook and get a vote or an independent price opinion, so investors can judge whether a proposed deal is fair and avoid being overridden by insiders.
form f-1 regulatory
"A registration statement on Form F-1 relating to these securities has been filed with the SEC"
A Form F-1 is the document a non-U.S. company files with U.S. regulators when it wants to sell stock or other securities to U.S. investors. It lays out the company’s business, finances, risks and how the offering will work, acting like a product manual and ingredient list so investors can judge what they’re buying. For investors, it’s a key source of verified information used to compare opportunities and assess potential reward and risk.
prospectus regulatory
"The offering is being made only by means of a prospectus"
A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.
registration statement regulatory
"A registration statement on Form F-1 relating to these securities has been filed"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WILMINGTON, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN) today announced the pricing of its initial public offering in the United States of 3,673,638 common shares at a public offering price of $4.50 per share and to certain investors, in lieu of common shares, pre-funded warrants to purchase 770,807 common shares at a purchase price of $4.4999 per pre-funded warrant, which represents the public offering price per share, minus the $0.0001 per share exercise price of each such pre-funded warrant. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Liberty, are expected to be approximately $20 million. In connection with the offering, Liberty has granted the underwriters a 30-day option to purchase up to an additional 666,666 common shares solely to cover over-allotments, if any.

The common shares are expected to begin trading on the Nasdaq Capital Market on April 22, 2026 under the symbol “DETX”. In connection with its listing on the Nasdaq Capital Market, the common shares will cease trading on the OTCQB® Venture Market under the symbol LDDFF. The common shares will continue to be listed for trading on the TSX Venture Exchange. The closing of the offering is expected to occur on April 23, 2026 subject to the satisfaction of customary closing conditions, including approval of the offering by the TSX Venture Exchange.

The Benchmark Company, LLC is acting as sole bookrunning manager for the offering.

Any securities issued pursuant to the offering to Canadian purchasers will be subject to a four-month hold period from the date of issuance under applicable Canadian securities laws.

William Frain, the Company’s Chief Executive Officer and Director, intends to purchase an aggregate of 5,555 common shares in the offering for gross proceeds of approximately $25,000. The participation by Mr. Frain in the offering constitutes a “related party transaction” within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The related party transactions will be exempt from minority approval, information circular and formal valuation requirements pursuant to the exemptions contained in Sections 5.5(a) and 5.7(1) of MI 61-101, as neither the fair market value of the gross securities issued under the offering nor the consideration paid by Mr. Frain exceeded 25% of the Company’s market capitalization.

A registration statement on Form F-1 relating to these securities has been filed with the SEC and was declared effective on March 31, 2026. The offering is being made only by means of a prospectus. Copies of the final prospectus relating to the offering, when available, may be obtained for free by visiting EDGAR on the website of the U.S. Securities and Exchange Commission (the “SEC”) at www.sec.gov. Alternatively, copies of the final prospectus, when available, may be obtained from The Benchmark Company, LLC at 150 East 58th Street, 17th Floor, New York, NY 10155, or by email at prospectus@benchmarkcompany.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About Liberty Defense
Liberty Defense (TSXV: SCAN) provides multi-technology security solutions for concealed weapons detection in high volume foot traffic areas and locations requiring enhanced security such as airports, stadiums, schools, and more. Liberty’s HEXWAVE product, for which the Company has secured an exclusive license from Massachusetts Institute of Technology (MIT), as well as a technology transfer agreement for patents related to active 3D radar imaging technology, provides discrete, modular, and scalable protection to provide layered, stand-off detection capability of metallic and non-metallic weapons. Liberty has also recently licensed the millimeter wave-based, High-Definition Advanced Imaging Technology (HD-AIT) body scanner and shoe scanner technologies as part of its technology portfolio. Liberty is committed to protecting communities and preserving peace of mind through superior security detection solutions.

Investor Relations

Crescendo Communications, LLC
SCAN@crescendo-ir.com
212-671-1020 

Forward-Looking Statements

When used in this press release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although Liberty believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in the forward-looking statements and information in this press release are reasonable, undue reliance should not be placed on them because Liberty can give no assurance that such statements will prove to be correct. Such statements and information reflect the current view of Liberty.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors and no assurance can be given that the proposed securities offering discussed above will be consummated on the terms described or at all. Completion of the proposed offering and the terms thereof are subject to numerous factors, many of which are beyond the control of Liberty, including, without limitation, market conditions, failure of customary closing conditions and the risk factors and other matters set forth in Liberty’s filings with the SEC. The forward-looking information contained in this press release includes statements relating to the Company’s expectations regarding the closing of the offering, intended use of proceeds and receipt of all regulatory approvals for the offering and represents the expectations of Liberty as of the date of this press release and, accordingly, are subject to change after such date. Liberty does not undertake to update this information at any particular time except as required in accordance with applicable law, including the securities laws of the United States and Canada.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.


FAQ

What price did Liberty Defense (DETX) set for its U.S. IPO on April 21, 2026?

The IPO was priced at $4.50 per common share. According to the company, pre-funded warrants were issued at $4.4999 representing the public price less a $0.0001 exercise price.

When will Liberty Defense (DETX) begin trading on Nasdaq following the April 21, 2026 announcement?

Common shares are expected to begin trading on April 22, 2026 on Nasdaq under the symbol DETX. According to the company, OTCQB trading will cease and TSX Venture listing will continue.

How much gross proceeds did Liberty Defense (DETX) expect from the offering announced April 21, 2026?

The offering is expected to generate approximately $20 million in gross proceeds before fees. According to the company, this figure is prior to underwriting discounts, commissions and estimated offering expenses.

What over-allotment option did Liberty Defense (DETX) grant in its April 21, 2026 IPO?

The company granted underwriters a 30-day option to purchase up to 666,666 additional common shares. According to the company, this option is solely to cover potential over-allotments.

Did Liberty Defense (DETX) disclose any insider participation in the April 21, 2026 offering?

Yes. Company CEO William Frain intends to purchase 5,555 common shares for about $25,000. According to the company, this participation is treated as a related party transaction with applicable exemptions.